Publications

2008

Neto BS, Smith GL, Mandeville JA, Vanni AJ, Wotkowicz C, Rieger-Christ KM, et al. Prognostic significance of altered p120 ctn expression in bladder cancer. BJU Int. 2008;101(6):746-52.
Kimmelman AC, Hezel AF, Aguirre AJ, Zheng H, Paik J-, Ying H, et al. Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci U S A. 2008;105(49):19372-7.
Plaza JA, Morrison C, Magro CM. Assessment of TCR-beta clonality in a diverse group of cutaneous T-Cell infiltrates. J Cutan Pathol. 2008;35(4):358-65.
Leone PE, Walker BA, Jenner MW, Chiecchio L, Dagrada G, Protheroe RK, et al. Deletions of CDKN2C in multiple myeloma: biological and clinical implications. Clin Cancer Res. 2008;14(19):6033-41.
Rutherford SC, Andemariam B, Philips SM, Elstrom RL, Chadburn A, Furman RR, et al. FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma. Leuk Lymphoma. 2008;49(4):719-26.
Wagner PL, Moo T-, Arora N, Liu Y-, Zarnegar R, Scognamiglio T, et al. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma. Ann Surg Oncol. 2008;15(10):2833-41.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700